Direct answer: Naltrexone-based support programs are prescription-driven services that may help some people with appetite regulation or weight-management strategies when used under clinician supervision; eligibility is determined case-by-case during a medical assessment and many candidates are evaluated for contraindications such as recent opioid use or seizure risk.
Ready to find out if you qualify? Start Free Assessment — No payment required
What a "Naltrexone Support" program means in telehealth
A Naltrexone Support program typically pairs clinical evaluation, medication management, and ongoing remote follow-up for people considering naltrexone or the combination product naltrexone/bupropion (the FDA-approved product CONTRAVE) as part of an overall weight-management plan. At EdenRx, the program integrates a board-certified provider review, treatment planning, and telehealth follow-ups available to patients in Florida and New York. The program is not an automatic prescription: it uses a structured medical assessment, medication counseling, and monitoring for safety and tolerability before any prescription is issued.
Key program pages and next steps: learn more about the official program hub at /programs/naltrexone-support and start with a free medical screening at /assessment. Additional program options include telehealth weight care at /weight-loss-online and GLP-1-focused pathways at /glp1-weight-loss-program.
Who may be eligible and common exclusions (checklist)
Eligibility is determined by clinical review and state licensure. Typical inclusion and exclusion considerations include:
- Inclusion considerations:
- Adults meeting medical criteria for prescription weight-management medications after clinical evaluation.
- Willingness to follow a care plan with regular telehealth follow-ups.
- No recent opioid exposure and willingness to disclose substance use history.
- Common exclusions and precautions:
- Active opioid use or opioid dependence (naltrexone can precipitate withdrawal).
- Untreated seizure disorder or medications that lower seizure threshold (bupropion component increases seizure risk).
- Pregnancy or breastfeeding (discuss alternatives with a clinician).
- Uncontrolled hypertension or certain psychiatric histories (bupropion carries warnings).
This checklist is illustrative, not exhaustive. For program-specific details and the full clinician checklist, start with /assessment or review program terms at /programs.
How cost typically works and what EdenRx currently provides
Cost components for a Naltrexone Support program may include an initial medical assessment, medication cost, and follow-up visits or care-management fees. For many telehealth platforms the pricing model includes:
- One-time or subscription-based telehealth visit fees for initial and follow-up appointments.
- Medication costs that depend on whether an FDA-approved product (e.g., CONTRAVE) or an alternative prescription is chosen; insurance coverage can vary.
- Ancillary costs (labs, specialist referrals) if clinically required.
EdenRx lists current pricing details and payment options at /pricing. Many patients compare expected out-of-pocket costs against insurance coverage and pharmacy pricing. If cost is a concern, discuss options during your /assessment — our providers review clinical necessity and, when appropriate, coordinate with local pharmacies.
Program process and what to expect from an EdenRx provider review
EdenRx’s provider-reviewed model is structured to prioritize safety and state telehealth rules. The typical process includes:
- Online screening via /assessment to capture medical history, medications, and goals.
- Licensed clinician review (providers are licensed in Florida or New York as required) and a telehealth visit to confirm suitability.
- Shared decision-making about medication options (including discussion of FDA-approved CONTRAVE vs off-label approaches) and baseline safety checks.
- Ongoing remote follow-up visits and messaging for medication adjustments and side-effect monitoring.
Important program notes: EdenRx clinicians will not prescribe naltrexone or naltrexone/bupropion if contraindications are present (for example, recent opioid use or uncontrolled seizure risk). The program also distinguishes between FDA-approved products and any compounded preparations; compounded medications are not the same as FDA-approved products and are subject to different regulatory standards.
See the primary program hub at /programs/naltrexone-support for the most current clinical flow and state-specific details. You can also explore other treatments and eligibility questions at /who-qualifies-for-weight-loss-medication and program alternatives at /programs.
Safety, contraindications and monitoring (table)
Below is a quick reference table summarizing safety issues to discuss with your provider.
| Safety Area | Key points | |---|---| | Opioid use | Naltrexone may precipitate opioid withdrawal. Recent opioid use is typically a contraindication. | | Seizure risk | Bupropion (part of CONTRAVE) lowers seizure threshold; avoid in uncontrolled seizure disorder. | | Pregnancy & breastfeeding | Discuss risks; many providers avoid initiating these medications during pregnancy. | | Psychiatric history | Bupropion can affect mood and has warnings about suicidal thoughts in certain populations; monitoring is required. | | Liver disease | Naltrexone is metabolized in the liver and requires caution in hepatic impairment. |
This table is a summary; the full safety review happens during the EdenRx clinician visit and intake labs when indicated.
Why Provider Review Matters
Provider review is central to safe, effective medication use. Naltrexone and naltrexone/bupropion combinations have specific pharmacology and safety profiles that require clinician judgment: confirming absence of opioid exposure, assessing seizure risk, verifying pregnancy status, and reviewing all medications to avoid interactions. Telehealth provider review at EdenRx ensures:
- State-licensed clinicians evaluate medical history and determine if a patient meets clinical criteria.
- Informed consent and counseling about potential side effects, expected monitoring, and alternative treatment paths such as GLP-1 options (/glp1-weight-loss-program).
- Structured follow-up to detect adverse events early and to modify therapy if needed.
Provider review also matters for regulatory compliance. EdenRx operates under Florida and New York telemedicine rules and maintains clinician licensure and documentation standards that support safe prescribing in those states.
Built from Eden Med Spa — real patients, real treatments.
Ready to find out if you qualify? Start Free Assessment — No payment required
Evidence base: what the literature and regulators say
Evidence for naltrexone and naltrexone/bupropion in weight management varies by product and indication. Key authoritative sources to consult include:
- FDA prescribing information for CONTRAVE (naltrexone HCl/bupropion HCl extended-release) which describes the clinical trials, approved indication for chronic weight management, and boxed warnings or contraindications. (See FDA prescribing information and product labeling.)
- FDA information on naltrexone hydrochloride as an opioid antagonist and its indications for alcohol dependence and opioid dependence; this label guidance is important because of the risk of precipitated withdrawal in patients who use opioids. (See FDA-approved labeling for naltrexone.)
- Peer-reviewed randomized controlled trials and systematic reviews indexed in PubMed that evaluate efficacy and safety of naltrexone/bupropion versus placebo for weight management; these are summarized in the CONTRAVE prescribing materials and in literature reviews accessible via PubMed/NIH.
How to interpret the evidence:
- The combination product CONTRAVE is FDA-approved for chronic weight management in appropriately selected adults. The approval is based on RCT data summarized in the official prescribing information.
- Single-agent naltrexone has different clinical indications (primarily alcohol and opioid dependence) and less robust evidence as a lone agent for weight loss; when naltrexone is discussed in weight-management contexts, it is commonly as part of combination therapy (e.g., with bupropion).
When reviewing evidence or claims online, always verify against primary sources: FDA labeling and peer-reviewed literature available through PubMed/NIH.
Cost & insurance considerations (quick guide)
- CONTRAVE (branded) may be covered by some insurance plans but often requires prior authorization; pharmacy prices vary and copay programs may be available through manufacturers.
- If an off-label prescription is considered, insurance coverage is more variable and medications may be paid out-of-pocket.
- Ask your EdenRx provider during /assessment about potential prior authorization needs and any patient assistance programs.
For specific, up-to-date cost details, visit /pricing and speak with your clinician during the assessment.
Frequently Asked Questions
Q: Is naltrexone the same as CONTRAVE? A: No. Naltrexone is an opioid antagonist available as a single-agent prescription for alcohol and opioid dependence. CONTRAVE is an FDA-approved combination product (naltrexone sustained-release plus bupropion sustained-release) specifically approved for chronic weight management in selected adults. Discuss differences with your EdenRx clinician.
Q: Will insurance cover a Naltrexone Support program or the medication? A: Coverage varies by plan and by the specific medication prescribed. CONTRAVE sometimes requires prior authorization. During your /assessment, EdenRx clinicians can discuss anticipated coverage, and you can reference /pricing for program fees.
Q: Can I get naltrexone if I’ve used opioids recently? A: Recent opioid use is an important safety concern. Naltrexone can precipitate opioid withdrawal. Full disclosure to your clinician is essential; if recent opioid use is present, alternative approaches are required.
Q: Are compounded naltrexone products equivalent to FDA-approved drugs? A: Compounded products are not the same as FDA-approved brand-name or generic medications; they are formulated by pharmacies to meet individual patient needs but are regulated differently. EdenRx clinicians will discuss FDA-approved options versus compounded alternatives and the regulatory distinctions.
Q: Do I need labs before starting a Naltrexone Support program? A: Providers may recommend baseline labs (for liver function, pregnancy testing, etc.) depending on medical history. The need for labs is determined during clinical review and /assessment.
Q: Is the EdenRx Naltrexone Support available nationwide? A: EdenRx provides services in Florida and New York only; prescriptions and clinical care are provided by clinicians licensed in those states and follow state telehealth rules.
Conclusion
A Naltrexone Support program delivers clinician-led assessment, medication counseling, and ongoing monitoring for people exploring naltrexone-containing options as part of weight-management care. Eligibility depends on individual medical history, state licensure, and safety screening (including opioid and seizure risk). EdenRx pairs state-licensed provider review with telehealth convenience for residents of Florida and New York. For detailed program terms, cost information, and to begin the eligibility process, visit /programs/naltrexone-support, review pricing at /pricing, or start a free screening at /assessment.
Ready to learn if you may be eligible? Start Free Assessment — No payment required
